Home > News > Glimepiride Introduction

Glimepiride Introduction

2019-10-23
Clinical use
Glimemide is a sulfonylurea oral hypoglycemic agent whose main mechanism of hypoglycemic action is to stimulate insulin for type II (non-islet dependent) diabetes. It is a new generation (third generation) sulfonylurea oral hypoglycemic agent.
Executive standard
Cp, usp
Specification packaging form
Bulk packaging cardboard drum

Next: Hydrocortisone Introduction

Home > News > Glimepiride Introduction
Related Products List

Home

Product

Whatsapp

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send